|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.30 SAR | +0.99% |
|
+6.06% | -3.53% |
| 08-06 | Avalon Pharma Posts Growth in H1 Net Profit, Revenue | MT |
| 07-17 | Derayah Financial Starts Avalon Pharma's Coverage at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 566M | - | - | - | - | - |
| 49.03B | |||||
| 42.33B | |||||
| 12.43B | |||||
| 11.68B | |||||
| 9.12B |
Select your edition
All financial news and data tailored to specific country editions
